Home      Tickers | SPY | NQ100 | DOW | Global | ETFs | Sector ETFs | 3x ETFs | ETF Movers | Stock Movers | Trading Alerts
     ^  AIM:  Intraday  Hourly  Forecast  Similar  Waves  GapOpen  Research  Timing  Gains  Losses  Strategies  Practice
     Tue. Dec. 28, 2010

Trading Signals: AIM Stock Price Prediction and Forecast (Tue. Jul. 28, 2009 - Mon. Mar. 9, 2020)

(AIM ImmunoTech Inc)

AIM latest price $269.3300 (-1.9%) ($269.2300 - $279.6800) on Tue. Dec. 28, 2010.


Trend Analysis and Forecast
 
Average Daily Percentage Swing  1.73% (three month average)
RSI   63
Latest Price   $269.3300(-1.9%)
Stocks Behave Similarly  Similar Stock List
Daily Trend  AIM advances 0.8% a day on average for past five trading days.
Weekly Trend  AIM advances 1.6% a week on average for past two weeks.
Market Behavior  Normal for large cap. Normal for small cap.
Correlated ETFs  Broad market will support AIM advance at 0% a week (0% probability)
  EWP(0%)    GLD(0%)    EWG(-1%)    EWI(-1%)    REMX(-1%)  
Factors Impacting AIM price  AIM will decline at least -0.865% in a week (0% probabilities).
  XLU(-9%)    XLP(-6%)    XLY(-4%)    TLT(-4%)    TIP(-4%)  
Explanation   The rally is not sustainable and not supported by the broad market.
 
 
Relative Volatility   (options are extremely cheap)
 
Market Trend Strength  -0.865% (StdDev 1.73%)
Hourly BBV   0 ()
Intraday Trend   -1.9%
  
 

  


5 Day Moving Average  $266.71(0.98%)
10 Day Moving Average  $263.96(2.03%)
20 Day Moving Average  $261.95(2.82%)
To recent high  -9.7%
To recent low  5.6%
Market Cap  $9.225b
 
 
 
AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL.

$. AIM price fluctuates within 1.92% (three month std-dev: 1.73%) daily (68% of days).

Sample size 3   Average positive next day return: 0.75%(33%)   Average negative next day return: -4.37%(67%)
Sample size 3   Average positive next three day return: 1.19%(33%)   Average negative next three day return: -3.82%(67%)
Sample size 3   Average positive next weekly return: 1.39%(33%)   Average negative next weekly return: -4.39%(67%)

Analysis   News   Options   Weekly Chart   Daily Chart   2 Month Daily Chart   

  >  20110128

iDateema100ema20ema10 ema5 Slow Hourly
Trend
Fast Hourly
Trend
ClosePatternTradePSMA5
BBV
 WTF lsma10
Trend
ema5
Trend
ema10
Trend
Volume
millions
Quarterly
Strength
100
Daily
Trend
Daily
Trend
Force
Daily
StdDev
Hourly
BBV
BBVRSIVIXCD